FISH analysis for B Lymphobasticleukaemia/lymphoma
|Specialist Integrated Haematological Malignancy Diagnostic Service (SIHMDS) >> Cytogenetics
FISH involves the application of fluorescent DNA probes specific to genes or genetic regions of interest that highlight abnormalities involving these regions.
Although acute lymphoblastic leukemia (ALL) is often considered a paediatric disease, nearly half of newly diagnosed ALL occurs in patients older than age 20. There are recurrent genomic findings that define the classification of ALL. Cytogenetic and FISH testing is delivered in line with the National Genomic Test Directory (NGTD) for Cancer.
A rapid FISH panel is performed on all diagnostic B-ALL cases and is reported within 3 calendar days.
|Sample & container required
|A minimum of 2-3mls Bone marrow in lithium heparin.
3-5mls peripheral blood in lithium heparin (if disease cells are present in sufficient numbers to allow cell culture and/or FISH studies, as appropriate)
EDTA PB and BM samples (>1ml) are acceptable for FISH only studies as appropriate.
Please note the laboratory does not provide transport medium. Samples sent in transport media from an external laboratory containing Lithium heparin will be accepted if no other media available
|Samples would not be rejected on the basis of small volume, however, 5 mL is ideal.
|Rapid FISH tests 3 calendar days
Urgent FISH/Karyotype: 95% should be reported within 14 calendar days
Post treatment follow-up samples are treated as routine; 95% should be reported within 21 calendar days
If the blood counts are abnormal (high or low white cell count) the volumes of BM/PB requested can be adjusted accordingly. For culture (karyotyping) a WCC of 5×10^6 cells per ml is optimal.